A Breast Cancer Vaccine (SV-BR-1-GM) in Combination With Pembrolizumab for the Treatment of Persistent, Recurrent, or Metastatic Breast Cancer

Conditions:   Anatomic Stage IV Breast Cancer AJCC v8;   Metastatic Breast Carcinoma;   Prognostic Stage IV Breast Cancer AJCC v8;   Recurrent Breast Carcinoma;   Refractory Breast Carcinoma Interventions:   Drug: Cyclophosphamide;   Biological: Allogeneic GM-CSF-secreting Breast Cancer Vaccine SV-BR-1-GM;   Biological: Pembrolizumab;   Biological: Recombinant Interferon Alpha 2b-like Protein;   Other: Questionnaire Administration;   Other: Quality of Life Assessment Sponsor:   Thomas Jefferson University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials